QRxPharma Ltd (QRX) - Financial and Strategic SWOT Analysis Review

October 2017 | 30 pages | ID: Q72FD8C6FCDEN
GlobalData

Abstracts

QRxPharma Ltd (QRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company’s abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

QRxPharma Ltd Key Recent Developments

Aug 22,2016: QRxPHARMA: Change Of Registered Office

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

QRxPharma Ltd - Key Facts
QRxPharma Ltd - Key Employees
QRxPharma Ltd - Major Products and Services
QRxPharma Ltd - History
QRxPharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

QRxPharma Ltd - Business Description
QRxPharma Ltd - Corporate Strategy
QRxPharma Ltd - SWOT Analysis
SWOT Analysis - Overview
QRxPharma Ltd - Strengths
QRxPharma Ltd - Weaknesses
QRxPharma Ltd - Opportunities
QRxPharma Ltd - Threats
QRxPharma Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
QRxPharma Ltd, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

QRxPharma Ltd, Key Facts
QRxPharma Ltd, Key Employees
QRxPharma Ltd, Major Products and Services
QRxPharma Ltd, History
QRxPharma Ltd, Subsidiaries
QRxPharma Ltd, Joint Venture
QRxPharma Ltd, Key Competitors
QRxPharma Ltd, Annual Ratios
QRxPharma Ltd, Annual Ratios (Cont.1)
QRxPharma Ltd, Interim Ratios
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
QRxPharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

QRxPharma Ltd, Performance Chart (2013 - 2017)
QRxPharma Ltd, Ratio Charts
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

UniQuest Pty Ltd
Spinifex Pharmaceuticals Pty Ltd
Molecular Pharmacology Limited